Trial Profile
A phase I, 2-part, open label study investigating pharmacokinetics of Belinostat and it's metabolites in patients with advanced solid tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jun 2017
Price :
$35
*
At a glance
- Drugs Belinostat (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- 17 Jun 2017 New trial record